...is there an opportunity here? Right now, Blog Boy is looking at ZOLL and DFIB. Searching for guidance. Will write more about these devices later in the week. Blog Boy holds no positions in either of these companies. Sign in to see full entry.
...Suze Orman gain relevancy in the world of investing? Sign in to see full entry.
Caremark RX is a pharmacy benefit management firm that's been rangebound since about August of last year. My guess is that a longer term breakout seems possible because of its present P/E of only 5.49 and recent analyst coverage starting CMX at a "buy." The "aging population" demographic also makes... Sign in to see full entry.
News just in...former "superstar" analyst Henry Blodget will be barred from Wall St. for life. Four million dollars in fines are to be levied against him. Jack Grubman is next on the list according to CNBC. Now where's that Mary Meeker at..... Sign in to see full entry.